| Name | 4-(phosphonomethyl)piperazine-2-carboxylic acid |
|---|
| Description | PMPA (NMDA antagonist) is an NMDA receptor antagonist with Ki values of 0.84, 2.74, 3.53 and 4.16 μM for NR2A, NR2B, NR2C and NR2D, respectively[1]. |
|---|---|
| Related Catalog | |
| Target |
Ki: 0.84 μM (NR2A), 2.74 μM (NR2B), 3.53 μM (NR2C), 4.16 μM (NR2D)[1] |
| References |
| Molecular Formula | C6H13N2O5P |
|---|---|
| Molecular Weight | 224.15200 |
| Exact Mass | 224.05600 |
| PSA | 119.91000 |
|
~%
113919-36-1 |
| Literature: Hays; Bigge; Novak; Drummond; Bobovski; Rice; Johnson; Brahce; Coughenour Journal of Medicinal Chemistry, 1990 , vol. 33, # 10 p. 2916 - 2924 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |